Ford’s Fathom midsize EV pickup opens at $29,945 as the first Universal EV platform vehicle, testing a radical assembly bet...
Starship's upper stage survived an intact ocean splashdown for the first time, clearing SpaceX toward attempting to catch the vehicle itself on Flight 14.
The Red Cross's second-ever blood crisis follows 2022 reforms that fixed hospital scheduling but never reached the aging donor pool now driving a four-year.
An FDA panel recommended six peptides, including BPC-157, for pharmacy use, lifting Hims stock 13% even as pricing and enforcement gaps suggest the gray market.
China's new domestic lithography machines and CXMT's blockbuster IPO show how years of US export controls fueled the competition now hitting Sandisk and ASML.
A second Canadian shipment missed the same US border check within a day of Maple Leaf's bacon recall, weeks before 50% tariffs begin.
Mamdani's city-run NYC grocery stores will cut meat and produce prices 30%, but independent bodega owners warn the tax-free subsidy could undercut them.
Major Pharmaceuticals recalled 12 subpotent levothyroxine lots and calls the health risk low, but the notice reached retailers, not the patients who take it daily.
A record Cyclospora outbreak is driving two in five Americans away from fresh produce and toward the processed snacks Kennedy's health agenda has targeted.
Ford's factory-warrantied customization packages chase the aftermarket just as a federal right-to-repair fix for independent shops stalls in Congress.
JetBlue's BlueFirst debuts by year end, but its basic fares mirror the unbundling playbook Delta and United ran first, cutting points, seat picks and lounge access.